Recent Breakthroughs in Psychopharmacology:
New for 2019! Optional, pre-conference Addiction and Medical Cannabis Workshops
Message from the Director, Henry A. Nasrallah, MD
On behalf of the University of Cincinnati and CURRENT PSYCHIATRY, it is my pleasure to invite you to attend our 18th Annual Psychopharmacology Update.
At this full-day course, nationally renowned faculty will focus on Recent Breakthroughs in Psychopharmacology: Novel Treatments
Topics will include:
- Long-Acting Injectables for Psychotic and Mood Disorders
- Emergence of Hallucinogens as Novel Treatments for Depression, Anxiety and PTSD
- Breakthrough Treatment for Postpartum Depression
- Botulinum Toxic for Depression
- Treatment for Clozapine-Resistant Psychosis
- Treating Parkinson's Disease Psychosis with a Non-Dopaminergic Agent
- Esketamine for Treatment-Resistant Depression
New for 2019 we are offering optional, pre-conference Addiction and Medical Cannabis Workshops on Friday, October 25. Workshops have limited space available. First come. First served!
This well-established one-day CME symposium offers an outstanding opportunity for education and networking with minimal disruption to your busy schedule. You will get in-depth analysis from our expert faculty and ample time to query them on topics that will help keep your practice ahead of the curve.
I look forward to hosting this symposium in Cincinnati at the Kingsgate Conference Center (across the street from UC Medical Center). I look forward to seeing past participants again, and many new faces as well!
Henry A. Nasrallah, MD
Professor of Psychiatry, Neurology and Neuroscience
Director, Neuropsychiatry Program
Director, Schizophrenia Program
University of Cincinnati College of Medicine
Saint Louis University School of Medicine